Early Detection of Pancreatic Cancer:
The Role of Industry in the Development of Biomarkers

Presented by Kenner Family Research Fund (KFRF)
in Partnership with the
American Pancreatic Association (APA)
Thursday, October 27, 4:30-6:45 pm


Early Detection of Pancreatic Cancer: The Role of industry in the Development of Biomarkers provides a unique and exciting opportunity to increase awareness of industry’s role in the development of biomarkers. Presentations include:

  • Current State of Biomarkers
    Sudhir Srivastava, PhD, PMH, MS, Chief, Cancer Biomarkers Research Group
    National Cancer Institute
  • GRAIL
    Anne-Renee Hartman, MD
    Medical Director and Director of Clinical Product Development
  • Immunovia
    Christer Wingren, PhD, Chief Technology Officer
    Laura Chirica, PhD, Chief Commercial Officer
  • Project Survival
    Niven R. Narain, MD, Co-founder, President and CEO, Berg
    A. James Moser, MD FACS, Co-Director, Pancreas and Liver Institute
    Beth Israel Deaconess Medical Center

Following the presentations, a conversation between the distinguished panelists and the audience will be facilitated by Suresh T. Chari, MD, Director of the Pancreas Clinic at Mayo Clinic and Anirban Maitra, MBBS, Scientific Director of the Sheikh Ahmed Bin Zayed Center for Pancreas Cancer Research at MD Anderson Cancer Center.

This Forum is a next step in the strategic plan initially set forth at the 2014 Early Detection of Sporadic Pancreatic Cancer Summit Conference presented by KFRF in partnership with the APA which provided a foundation for the field (“Early Detection of Sporadic Pancreatic Cancer: Summative Review.” Pancreas July 2015 - Volume 44 - Issue 5 - p 693–712) and led to the creation of a defined pathway for the future(“Early Detection of Sporadic Pancreatic Cancer: Strategic Map for Innovation—A White Paper.” Pancreas July 2015 - Volume 44 - Issue 5 - p 686–692).

The 2015 Forum, Early Detection: Lessons Learned from Other Cancers, provided historical perspective on the critical barriers to achieving progress in breast, prostate and colon cancers and how this knowledge could be applied to the early detection of pancreatic cancer (“Early Detection of Pancreatic Cancer—a Defined Future Using Lessons From Other Cancers: A White Paper.” Pancreas September 2016 - Volume 45 - Issue 8 - p 1073–1079).

Kenner Family Research Fund, a registered 501(c) 3 organization, is committed to investing in initiatives to establish an early detection protocol for pancreatic cancer. The fund was formed by family and friends in memory of Peter Kenner.